Citations

Mayo Clinic

Showing 10 of 108572 citations.

Tumor necrosis factor alpha derived from classically activated “M1” macrophages reduces interstitial cell of Cajal numbers
Eisenman, Seth T., Verhulst, Pieter–Jan, Cipriani, Gianluca , Saur, Dieter , Farrugia, Gianrico , Gibbons, Simon J. , Saur, Dieter

Neurogastroenterology & Motility | October 25, 2016 | Volume: 29 | Issue: 4 | Pages: No page available

10.1111/nmo.12984 | PMID 27781339 Get It

Abstract Background Delayed gastric emptying in diabetic mice and humans is associated with changes in macrophage phenotype and loss of interstitial cells of Cajal ( ICC ) in the gastric muscle layers. In diabetic mice, classically activated M1 macrophages are associated with delayed gastric emptying, whereas alternatively activated M2 macrophages are associated with normal gastric emptying. This study aimed to determine if secreted factors from M1 macrophages could injure mouse ICC in primary culture. Methods Cultures of gastric ICC were treated with conditioned medium ( CM ) from activated bone marrow‐derived macrophages ( BMDM s) and the effect of CM was quantified by counting ICC per high‐powered field. Key Results Bone marrow‐derived macrophages were activated to a M1 or M2 phenotype confirmed by qRT ‐ PCR . Conditioned medium from M1 macrophages reduced ICC numbers by 41.1%, whereas M2‐ CM had no effect as compared to unconditioned, control media. Immunoblot analysis of 40 chemokines/cytokines found 12 that were significantly increased in M1‐ CM , including tumor necrosis factor alpha ( TNF ‐α). ELISA detected 0.697±0.03 ng mL −1 TNF ‐α in M1‐ CM . Recombinant mouse TNF ‐α reduced Kit expression and ICC numbers in a concentration‐dependent manner ( EC 50 = 0.817 ng mL −1 ). Blocking M1‐ CM TNF ‐α with a neutralizing antibody preserved ICC numbers. The caspase inhibitor Z‐ VAD .fmk partly preserved ICC numbers (cells/field; 6.63±1.04, 9.82±1.80 w/Z‐ VAD .fmk, n=6, P <.05). Conclusions & Inferences This work demonstrates that TNF ‐α secreted from M1 macrophages can result in Kit loss and directly injure ICC in vitro partly through caspase‐dependent apoptosis and may play an important role in ICC depletion in diabetic gastroparesis.
Hernia Sac Presence Portends Better Survivability of Isolated Congenital Diaphragmatic Hernia with “Liver-Up”
Vuković, Jurica , Novak, Milivoj, Schroeder, Darrell R. , Grizelj, Ruža, Bojanić, Katarina , Grizelj, Ruža , Weingarten, Toby N. , Šprung, Juraj , Schroeder, Darrell

American Journal of Perinatology | October 25, 2016 | Volume: 34 | Issue: 05 | Pages: 515-519

10.1055/s-0036-1593765 | PMID 27780277 Get It

Portopulmonary hypertension and liver transplantation: A duo in question
Krowka, Michael J. , Heimbach, Julie K.

Liver Transplantation | October 25, 2016 | Volume: 22 | Issue: 12 | Pages: 1633-1634

10.1002/lt.24664 | PMID 27779823 Get It

Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage
Fortune, Brett E. , García–Tsao, Guadalupe , Deng, Yanhong , Fallon, Michael B. , Sigal, Samuel H. , Chalasani, Naga , Lim, Joseph K. , Reuben, Adrian , Vargas, Hugo E. , Abrams, Gary A. , Lewis, Michele D. , Hassanein, Tarek , Trotter, James F. , Beavers, Kimberly L. , Ganger, Daniel , Thuluvath, Paul J. , Grace, Norman D., Groszmann, Roberto J., Ciarleglio, Maria , Sanyal, Arun J. , Vargas, Hugo E , Lewis, Michele D

Journal of Clinical Gastroenterology | October 25, 2016 | Volume: 51 | Issue: 5 | Pages: 446-453

10.1097/mcg.0000000000000733 | PMID 27779613 Get It

Goals/Background: Data on acute variceal hemorrhage (AVH) in the United States is limited and the best method to stratify risk is not clear. Taking advantage of a prospective US cohort study, we aimed to (1) describe clinical outcomes of AVH and their predictors; (2) compare predictors of 6-week mortality. Study: Prospective 15-center US cohort of patients with cirrhosis presenting with endoscopically proven AVH, all of whom received antibiotics, vapreotide (a somatostain analog) infusion and endoscopic band ligation. Patients were enrolled between August 2006 and April 2008. Primary outcome was 6-week mortality. Secondary outcome was 5-day treatment failure. The prognostic value of Child-Turcotte-Pugh (CTP) class, Model for End-stage Liver Disease (MELD) score and a recent recalibrated MELD were compared. Results: Seventy eligible patient were enrolled; 18 (26%) patients died within 6-weeks of index bleed. Demographic, clinical, and laboratory data were compared between survivors and nonsurvivors. Multivariate models showed that admission CTP or the MELD score (separately) were independent predictors of survival. The discriminative values of CTP (area under receiver operating characteristic: 0.75) and MELD (area under receiver operating characteristic: 0.79) were good and not significantly different (P=0.27). However, calibration (correlation between observed and predicted mortality) test was significantly better for CTP than for MELD, with the recently described recalibrated MELD model having the worst agreement. Predicted mortality for CTP-A was <10%, CTP-B 10% to 30%; and CTP-C >33%. Conclusions: AVH mortality of 26% in the United States is in the upper range limit compared with recent series but may be due to inclusion of patients with more advanced cirrhosis. CTP score has the best overall performance in the prediction of 6-week mortality and is best at stratifying risk.
Willingness to Be a Brain Donor
Boise, Linda, Hinton, Ladson , Rosen, Howard J. , Ruhl, Mary C., Albert, Marilyn , Denny, Andrea, Hughes, Travonia, Lingler, Jennifer H. , Morhardt, Darby, Parfitt, Francine, Peterson-Hazan, Susan, Pop, Viorela, Rose, Tara , Shah, Raj C. , Hinton, Ladson , Dodge, Hiroko Hayama , Mattek, Nora , Grill, Joshua D. , Shah, Raj C

Alzheimer Disease & Associated Disorders | October 25, 2016 | Volume: 31 | Issue: 2 | Pages: 135-140

10.1097/wad.0000000000000174 | PMID 27779492 Get It

Introduction: Racial and ethnic groups are under-represented among research subjects who assent to brain donation in Alzheimer disease research studies. There has been little research on this important topic. Although there are some studies that have investigated the barriers to brain donation among African American study volunteers, there is no known research on the factors that influence whether or not Asians or Latinos are willing to donate their brains for research. Methods: African American, Caucasian, Asian, and Latino research volunteers were surveyed at 15 Alzheimer Disease Centers to identify predictors of willingness to assent to brain donation. Results: Positive predictors included older age, Latino ethnicity, understanding of how the brain is used by researchers, and understanding of what participants need to do to ensure that their brain will be donated. Negative predictors included African/African American race, belief that the body should remain whole at burial, and concern that researchers might not be respectful of the body during autopsy. Discussion: The predictive factors identified in this study may be useful for researchers seeking to increase participation of diverse ethnic groups in brain donation.
Endogenous Protease Inhibitors in Airway Epithelial Cells Contribute to Eosinophilic Chronic Rhinosinusitis
Kouzaki, Hideaki , Matsumoto, Koji , Kikuoka, Hirotaka , Shimizu, Shino , Kita, Hirohito , Shimizu, Takeshi , Shimizu, Shino , Shimizu, Takeshi , Kato, Tomohisa , Tojima, Ichiro , Kita, H

American Journal of Respiratory and Critical Care Medicine | October 25, 2016 | Volume: 195 | Issue: 6 | Pages: 737-747

10.1164/rccm.201603-0529oc | PMID 27779422 Get It

Abstract Rationale Cystatin A and SPINK5 are endogenous protease inhibitors (EPIs) that may play key roles in epithelial barrier function. Objectives To investigate the roles of EPIs in the pathogenesis of chronic rhinosinusitis (CRS). Methods We examined the expression of cystatin A and SPINK5 in the nasal epithelial cells of patients with CRS. Additionally, the in vitro effects of recombinant EPIs on the secretion of the epithelial-derived cytokines IL-25, IL-33, and thymic stromal lymphopoietin in airway epithelial cells, and the in vivo effects of recombinant EPIs in the nasal epithelium of mice exposed to multiple airborne allergens (MAA) were examined. Measurements and Main Results Compared with control subjects and patients with noneosinophilic CRS, patients with eosinophilic CRS showed significantly lower protein and mRNA expression of cystatin A and SPINK5 in the nasal epithelium. Allergen-induced production of IL-25, IL-33, and thymic stromal lymphopoietin in normal human bronchial epithelial cells was inhibited by treatment with recombinant cystatin A or SPINK5. Conversely, the production of these cytokines was increased when cystatin A or SPINK5 were knocked down with small interfering RNA. Chronic MAA exposure induced goblet cell metaplasia and epithelial disruption in mouse nasal epithelium and decreased the tissue expression and nasal lavage levels of cystatin A and SPINK5. Intranasal instillations of recombinant EPIs attenuated this MAA-induced pathology. Conclusions Cystatin A and SPINK5 play an important role in protecting the airway epithelium from exogenous proteases. The preservation of EPIs may have a therapeutic benefit in intractable airway inflammation, such as eosinophilic CRS.
Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study
Savica, Rodolfo , Grossardt, Brandon R. , Bower, James H., Ahlskog, J. Eric , Rocca, Walter A. , Mielke, Michelle M. , Grossardt, Brandon R

Movement Disorders | October 25, 2016 | Volume: 32 | Issue: 2 | Pages: 227-234

10.1002/mds.26839 | PMID 27779780 Get It

ABSTRACT Background Epidemiological studies of drug‐induced parkinsonism remain limited. Objectives To investigate the incidence and time trends of drug‐induced parkinsonism over 30 years in a geographically defined American population. Methods We used the medical records‐linkage system of the Rochester Epidemiology Project to identify all persons in Olmsted County, Minnesota, who received a screening diagnostic code for parkinsonism from 1976 through 2005. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of drug‐induced parkinsonism associated with dopamine‐blocking or dopamine‐depleting medications. Results Among 906 incident cases of parkinsonism from 1976 to 2005, 108 persons had drug‐induced parkinsonism (11.9%). The average annual incidence rate of drug‐induced parkinsonism was 3.3 per 100,000 person‐years, was higher in women, and increased with older age. Drug‐induced parkinsonism was the fifth‐most common type of parkinsonism overall; however, it was the most common type among persons younger than age 40 years. Typical antipsychotic drugs were the most common class of drugs associated with parkinsonism, whereas atypical antipsychotic drugs were rarely involved. The incidence rate of drug‐induced parkinsonism decreased 32.0% per decade (relative risk = 0.68; 95% confidence interval: 0.49–0.94) and 68.6% over the 30 years of the study. The decrease was similar in men (65.2%) and women (69.4%); however, the trend was significant only in women. Conclusions The incidence of drug‐induced parkinsonism increased with older age and was higher in women at all ages. Typical antipsychotic drugs were the most common cause. The incidence of drug‐induced parkinsonism decreased over the 30 years of the study because of changes in drug use. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Use of the term “rule out” in requisition forms may cause diagnostic delays in dermatopathology practice
Abdou, Yara , Lohse, Christine M. , Comfere, Nneka I. , Lohse, Christine, Abdou, Yara George

International Journal of Dermatology | October 25, 2016 | Volume: 56 | Issue: 1 | Pages: 86-91

10.1111/ijd.13403 | PMID 27778322 Get It

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study
Neal‐Perry, Genevieve , Pal, Lubna , Løbo, Rogerio A. , Black, Dennis M. , Budoff, Matthew J. , Cedars, Marcelle I. , Dowling, N. Maritza , Dunn, Mary Hunzicker, Gleason, Carey E. , Hodis, Howard N., Isaac, Barbara, Magnani, Maureen, Miller, Virginia M. , Taylor, Hugh S. , Wharton, Whitney , Wolff, E.F., Zepeda, Viola, Harman, S. Mitchell , Santoro, Nanette, Santoro, Nanette F. , Allshouse, Amanda A. , Naftolin, Frederick , Brinton, Eliot A. , Manson, JoAnn E. , Budoff, Matthew

Menopause | October 25, 2016 | Volume: 24 | Issue: 3 | Pages: 238-246

10.1097/gme.0000000000000756 | PMID 27779568 Get It

Abstract Objective: The objective of the present study was to compare the efficacy of two forms of menopausal hormone therapy in alleviating vasomotor symptoms, insomnia, and irritability in early postmenopausal women during 4 years. Methods: A total of 727 women, aged 42 to 58, within 3 years of their final menstrual period, were randomized to receive oral conjugated estrogens (o-CEE) 0.45 mg (n = 230) or transdermal estradiol (t-E 2 ) 50 μg (n = 225; both with micronized progesterone 200 mg for 12 d each mo), or placebos (PBOs; n = 275). Menopausal symptoms were recorded at screening and at 6, 12, 24, 36, and 48 months postrandomization. Differences in proportions of women with symptoms at baseline and at each follow-up time point were compared by treatment arm using exact χ 2 tests in an intent-to-treat analysis. Differences in treatment effect by race/ethnicity and body mass index were tested using generalized linear mixed effects modeling. Results: Moderate to severe hot flashes (from 44% at baseline to 28.3% for PBO, 7.4% for t-E 2 , and 4.2% for o-CEE) and night sweats (from 35% at baseline to 19% for PBO, 5.3% for t-E 2 , and 4.7% for o-CEE) were reduced significantly by 6 months in women randomized to either active hormone compared with PBO ( P < 0.001 for both symptoms), with no significant differences between the active treatment arms. Insomnia and irritability decreased from baseline to 6 months postrandomization in all groups. There was an intermittent reduction in insomnia in both active treatment arms versus PBO, with o-CEE being more effective than PBO at 36 and 48 months ( P = 0.002 and 0.05) and t-E 2 being more effective than PBO at 48 months ( P = 0.004). Neither hormone treatment significantly affected irritability compared with PBO. Symptom relief for active treatment versus PBO was not significantly modified by body mass index or race/ethnicity. Conclusions: Recently postmenopausal women had similar and substantial reductions in hot flashes and night sweats with lower-than-conventional doses of oral or transdermal estrogen. These reductions were sustained during 4 years. Insomnia was intermittently reduced compared with PBO for both hormone regimens.
Baseline impedance measured during high‐resolution esophageal impedance manometry reliably discriminates GERD patients
Geno, Debra M., Vela, Marcelo F. , Katzka, David A. , Ravi, Karthik , Crowell, Michael D.

Neurogastroenterology & Motility | October 25, 2016 | Volume: 29 | Issue: 5 | Pages: No page available

10.1111/nmo.12974 | PMID 27778419 Get It

Abstract Background Baseline impedance measured with ambulatory impedance pH monitoring ( MII ‐pH) and a mucosal impedance catheter detects gastroesophageal reflux disease ( GERD ). However, these tools are limited by cost or patient tolerance. We investigated whether baseline impedance measured during high‐resolution impedance manometry ( HRIM ) distinguishes GERD patients from controls. Methods Consecutive patients with clinical HRIM and MII ‐pH testing were identified. Gastroesophageal reflux disease was defined by esophageal pH <4 for ≥5% of both the supine and total study time, whereas controls had an esophageal pH <4 for ≤3% of the study performed off PPI . Baseline impedance was measured over 15 seconds during the landmark period of HRIM and over three 10 minute intervals during the overnight period of MII ‐pH. Key Results Among 29 GERD patients and 26 controls, GERD patients had a mean esophageal acid exposure time of 22.7% compared to 1.2% in controls ( P <.0001). Mean baseline impedance during HRIM was lower in GERD (1061 Ω) than controls (2814 Ω) ( P <.0001). Baseline mucosal impedance measured during HRIM and MII ‐pH correlated ( r =0.59, P <.0001). High‐resolution esophageal manometry baseline impedance had high diagnostic accuracy for GERD , with an area under the curve ( AUC ) of 0.931 on receiver operating characteristics ( ROC ) analysis. A HRIM baseline impedance threshold of 1582 Ω had a sensitivity of 86.2% and specificity of 88.5% for GERD , with a positive predictive value of 89.3% and negative predictive value of 85.2%. Conclusions & Inferences Baseline impedance measured during HRIM can reliably discriminate GERD patients with at least moderate esophageal acid exposure from controls. This diagnostic tool may represent an accurate, cost‐effective, and less invasive test for GERD .